ZCZL Industrial Technology Group (00564) released annual performance, with net profit attributable to shareholders of approximately 4.306 billion yuan, a year-on-year increase of 9.2%.
Sino Innovation Group (00564) announced its annual performance for the year ending December 31, 2025, with operating income of 41.346 billion yuan, a year-on-year increase of 11.59%. Net profit attributable to shareholders of the listed company is expected to be around 4.306 billion yuan, a year-on-year increase of 9.2%. Basic earnings per share is 2.4546 yuan, and a final dividend of 1.25 yuan per 10 shares is proposed.
ZCZL Industrial Technology Group (00564) announced its annual performance for the year ending December 31, 2025, with operating income of RMB 41.346 billion, representing a year-on-year increase of 11.59%. Net profit attributable to shareholders of the listed company was around RMB 4.306 billion, up by 9.2% year-on-year. Basic earnings per share were RMB 2.4546, with a proposed final dividend of RMB 12.50 for every 10 shares.
The announcement stated that the revenue growth was mainly driven by an increase in revenue of RMB 1.649 billion in the coal mining machinery manufacturing segment, RMB 2.397 billion in the automotive components manufacturing segment, and RMB 2.47 billion in the industrial intelligent products segment.
Related Articles

PASHUN INT'L (00574) announced a net loss of 15.856 million yuan in 2025, a year-on-year increase of 3.55%.

Understanding Jiuyuan Gene (02566) 2025 annual performance in one picture: Performance remains resilient, focusing on research and development to enhance long-term competitiveness.

GMTEight List of A-share restricted sales and lifting restrictions | March 31st
PASHUN INT'L (00574) announced a net loss of 15.856 million yuan in 2025, a year-on-year increase of 3.55%.

Understanding Jiuyuan Gene (02566) 2025 annual performance in one picture: Performance remains resilient, focusing on research and development to enhance long-term competitiveness.

GMTEight List of A-share restricted sales and lifting restrictions | March 31st

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


